Mays TA - Search Results

1

Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

Rafael-Fortney JA, Chimanji NS, Schill KE, Martin CD, Murray JD, Ganguly R, Stangland JE, Tran T, Xu Y, Canan BD, Mays TA, Delfín DA, Janssen PM, Raman SV. Rafael-Fortney JA, et al. Among authors: mays ta. Circulation. 2011 Aug 2;124(5):582-8. doi: 10.1161/CIRCULATIONAHA.111.031716. Epub 2011 Jul 18. Circulation. 2011. PMID: 21768542 Free PMC article.

2

Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model.

Delfín DA, Xu Y, Schill KE, Mays TA, Canan BD, Zang KE, Barnum JA, Janssen PM, Rafael-Fortney JA. Delfín DA, et al. Among authors: mays ta. Mol Ther. 2012 Jul;20(7):1378-83. doi: 10.1038/mt.2012.81. Epub 2012 May 1. Mol Ther. 2012. PMID: 22547149 Free PMC article.

3

Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.

Janssen PM, Hiranandani N, Mays TA, Rafael-Fortney JA. Janssen PM, et al. Among authors: mays ta. Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2373-8. doi: 10.1152/ajpheart.00448.2005. Epub 2005 Jul 15. Am J Physiol Heart Circ Physiol. 2005. PMID: 16024571 Free article.

4

Claudin-5 levels are reduced in human end-stage cardiomyopathy.

Mays TA, Binkley PF, Lesinski A, Doshi AA, Quaile MP, Margulies KB, Janssen PM, Rafael-Fortney JA. Mays TA, et al. J Mol Cell Cardiol. 2008 Jul;45(1):81-7. doi: 10.1016/j.yjmcc.2008.04.005. Epub 2008 Apr 25. J Mol Cell Cardiol. 2008. PMID: 18513742

5

Truncated CASK does not alter skeletal muscle or protein interactors.

Sanford JL, Mays TA, Varian KD, Wilson JB, Janssen PM, Rafael-Fortney JA. Sanford JL, et al. Among authors: mays ta. Muscle Nerve. 2008 Sep;38(3):1116-27. doi: 10.1002/mus.20993. Muscle Nerve. 2008. PMID: 18642383

6

Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice.

Sanford JL, Edwards JD, Mays TA, Gong B, Merriam AP, Rafael-Fortney JA. Sanford JL, et al. Among authors: mays ta. J Mol Cell Cardiol. 2005 Feb;38(2):323-32. doi: 10.1016/j.yjmcc.2004.11.025. Epub 2005 Jan 22. J Mol Cell Cardiol. 2005. PMID: 15698839

7

CASK localizes to nuclei in developing skeletal muscle and motor neuron culture models and is agrin-independent.

Gardner KL, Sanford JL, Mays TA, Rafael-Fortney JA. Gardner KL, et al. Among authors: mays ta. J Cell Physiol. 2006 Jan;206(1):196-202. doi: 10.1002/jcp.20449. J Cell Physiol. 2006. PMID: 15965905

8

CASK and Dlg form a PDZ protein complex at the mammalian neuromuscular junction.

Sanford JL, Mays TA, Rafael-Fortney JA. Sanford JL, et al. Among authors: mays ta. Muscle Nerve. 2004 Aug;30(2):164-71. doi: 10.1002/mus.20073. Muscle Nerve. 2004. PMID: 15266631

9

Glutamate receptors localize postsynaptically at neuromuscular junctions in mice.

Mays TA, Sanford JL, Hanada T, Chishti AH, Rafael-Fortney JA. Mays TA, et al. Muscle Nerve. 2009 Mar;39(3):343-9. doi: 10.1002/mus.21099. Muscle Nerve. 2009. PMID: 19208409 Free PMC article.

10

Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors.

Shimizu T, LoRusso PM, Papadopoulos KP, Patnaik A, Beeram M, Smith LS, Rasco DW, Mays TA, Chambers G, Ma A, Wang J, Laliberte R, Voi M, Tolcher AW. Shimizu T, et al. Among authors: mays ta. Clin Cancer Res. 2014 Oct 1;20(19):5032-40. doi: 10.1158/1078-0432.CCR-14-0570. Epub 2014 Aug 8. Clin Cancer Res. 2014. PMID: 25107918 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters